Clinical Trials List
2024-11-15 - 2033-12-31
Phase III
Recruiting9
ICD-10B33.8
Other specified viral diseases
ICD-10B34.1
Enterovirus infection, unspecified
ICD-10B34.2
Coronavirus infection, unspecified
ICD-10B34.3
Parvovirus infection, unspecified
ICD-10B34.4
Papovavirus infection, unspecified
ICD-10B34.8
Other viral infections of unspecified site
ICD-10B97.19
Other enterovirus as the cause of diseases classified elsewhere
ICD-10B97.21
SARS-associated coronavirus as the cause of diseases classified elsewhere
ICD-10B97.29
Other coronavirus as the cause of diseases classified elsewhere
ICD-10B97.5
Reovirus as the cause of diseases classified elsewhere
ICD-10B97.6
Parvovirus as the cause of diseases classified elsewhere
ICD-10B97.81
Human metapneumovirus as the cause of diseases classified elsewhere
ICD-10B97.89
Other viral agents as the cause of diseases classified elsewhere
ICD-9079.89
Other specified viral infection in conditions classified elsewhere and of unspecified site
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 李智晃 無
- 鄭鈞文 無
- Cheng-Ta Yang Division of Thoracic Medicine
- 黃集仁 無
- Tung-Liang Lin Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
- Po-Yan Huang 無
- 謝顯森 無
- Tsong-Hai Lee Division of Neurology
- 詹逸凌 無
- Hung Chang Division of Hematology & Oncology
- 蘇羿囷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yuan Lee 無
- Chung-Hao Huang 無
- 郭弘典 無
- 張雅婷 無
- Shang-Yi Lin 無
- Po-Liang Lu 無
- Tun-Chieh Chen 無
- 林麗玫 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王振宇 無
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- 莊子逸 無
- Huey-En Tzeng Division of Hematology & Oncology
- 林奕宏 無
- 林詩萍 Division of Infectious Disease
- 黃丞正 無
- Po-Yu Liu Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 江振源 Division of Thoracic Medicine
- Han-Lin Hsu Division of Thoracic Medicine
- Kuan-Jen Bai Division of Thoracic Medicine
- Shian-Jiun Lin Division of Thoracic Medicine
- 楊善堯 Division of Thoracic Medicine
- Chih-Hsin Lee Division of Thoracic Medicine
- Yu-Tien Tzeng Division of Thoracic Medicine
- 石智元 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
56 participants
-
Global
3082 participants
